Kewei Wang

1.5k total citations
38 papers, 1.2k citations indexed

About

Kewei Wang is a scholar working on Biomedical Engineering, Molecular Biology and Biomaterials. According to data from OpenAlex, Kewei Wang has authored 38 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Biomedical Engineering, 18 papers in Molecular Biology and 11 papers in Biomaterials. Recurrent topics in Kewei Wang's work include Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (11 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Kewei Wang is often cited by papers focused on Nanoplatforms for cancer theranostics (23 papers), Nanoparticle-Based Drug Delivery (11 papers) and Advanced biosensing and bioanalysis techniques (7 papers). Kewei Wang collaborates with scholars based in China, United States and Germany. Kewei Wang's co-authors include Youyong Yuan, Yalan Tu, Qingyu Zong, Yansong Dong, Maolin Jiang, Jun Wang, Xuan Xiao, Ye Liu, Papasani V. Subbaiah and Cong‐Fei Xu and has published in prestigious journals such as Advanced Materials, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Kewei Wang

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kewei Wang China 21 644 559 319 278 149 38 1.2k
Hongzhuo Liu China 23 524 0.8× 518 0.9× 532 1.7× 252 0.9× 107 0.7× 58 1.5k
Boxuan Ma China 21 695 1.1× 330 0.6× 443 1.4× 497 1.8× 114 0.8× 36 1.3k
Shiyi Zuo China 17 744 1.2× 463 0.8× 609 1.9× 199 0.7× 74 0.5× 34 1.2k
Dengshuai Wei China 20 786 1.2× 561 1.0× 408 1.3× 416 1.5× 169 1.1× 29 1.4k
Batakrishna Jana India 20 567 0.9× 734 1.3× 623 2.0× 401 1.4× 185 1.2× 60 1.6k
Xiuli Zheng China 19 716 1.1× 451 0.8× 598 1.9× 337 1.2× 151 1.0× 42 1.3k
Lei Luo China 17 484 0.8× 244 0.4× 256 0.8× 289 1.0× 147 1.0× 47 1.0k
Wenjun Le China 17 839 1.3× 482 0.9× 440 1.4× 461 1.7× 71 0.5× 40 1.5k
Leilei Shi China 24 792 1.2× 479 0.9× 364 1.1× 489 1.8× 142 1.0× 66 1.5k
Yang‐Bao Miao China 24 817 1.3× 758 1.4× 445 1.4× 387 1.4× 54 0.4× 49 1.8k

Countries citing papers authored by Kewei Wang

Since Specialization
Citations

This map shows the geographic impact of Kewei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewei Wang more than expected).

Fields of papers citing papers by Kewei Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kewei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewei Wang. The network helps show where Kewei Wang may publish in the future.

Co-authorship network of co-authors of Kewei Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kewei Wang. A scholar is included among the top collaborators of Kewei Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kewei Wang. Kewei Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Maolin, Ye Liu, Kewei Wang, et al.. (2025). Mutually reinforced activatable NIR fluorescence/MR bimodal imaging enabled by tumor-specific biomarker amplification. 1(4). 100044–100044. 2 indexed citations
2.
Wang, Kewei, Maolin Jiang, Ye Liu, et al.. (2024). A Synergistic Chemoimmunotherapy System Leveraging PD‐L1 Blocking and Bioorthogonal Prodrug Activation. Advanced Materials. 36(30). e2402322–e2402322. 16 indexed citations
3.
4.
Wang, Chaoyu, Yaru Li, Zhifang Jia, et al.. (2024). A covalent organic framework-based nanoplatform with enhanced photothermal and photodynamic performance for targeted tumor therapy. Materials Chemistry Frontiers. 8(16). 2736–2744. 4 indexed citations
5.
Liu, Ye, et al.. (2023). Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy. Acta Biomaterialia. 166. 567–580. 12 indexed citations
6.
7.
Wang, Kewei, Maolin Jiang, Yansong Dong, et al.. (2022). Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity. Journal of Controlled Release. 348. 1004–1015. 8 indexed citations
8.
Jiang, Maolin, Ye Liu, Yansong Dong, Kewei Wang, & Youyong Yuan. (2022). Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy. Biomaterials. 284. 121480–121480. 24 indexed citations
9.
Wang, Kewei, Xuan Xiao, Ye Liu, et al.. (2022). Self-immolative polyprodrug-based tumor-specific cascade amplificated drug release nanosystem for orchestrated synergistic cancer therapy. Biomaterials. 289. 121803–121803. 25 indexed citations
10.
Lei, Xing, Kewei Wang, Jin Hao, et al.. (2021). Recognize the role of CD146/MCAM in the osteosarcoma progression: an in vitro study. Cancer Cell International. 21(1). 300–300. 8 indexed citations
11.
Zong, Qingyu, Kewei Wang, Xuan Xiao, et al.. (2021). Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversal. Biomaterials. 276. 121005–121005. 34 indexed citations
12.
Xiao, Xuan, Kewei Wang, Qingyu Zong, et al.. (2021). Polyprodrug with glutathione depletion and cascade drug activation for multi-drug resistance reversal. Biomaterials. 270. 120649–120649. 63 indexed citations
13.
Liu, Ye, Maolin Jiang, Yalan Tu, et al.. (2021). Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy. Biomaterials. 278. 121136–121136. 18 indexed citations
14.
Jiang, Maolin, Kewei Wang, Xuan Xiao, et al.. (2021). Theranostic Heterodimeric Prodrug with Dual‐Channel Fluorescence Turn‐On and Dual‐Prodrug Activation for Synergistic Cancer Therapy. Advanced Healthcare Materials. 10(21). e2101144–e2101144. 14 indexed citations
15.
Tu, Yalan, Yansong Dong, Kewei Wang, et al.. (2020). Intercellular delivery of bioorthogonal chemical receptors for enhanced tumor targeting and penetration. Biomaterials. 259. 120298–120298. 48 indexed citations
16.
Dong, Yansong, Yalan Tu, Kewei Wang, et al.. (2020). A General Strategy for Macrotheranostic Prodrug Activation: Synergy between the Acidic Tumor Microenvironment and Bioorthogonal Chemistry. Angewandte Chemie. 132(18). 7235–7239. 30 indexed citations
17.
Yang, Xifei, et al.. (2019). Optogenetics-induced activation of glutamate receptors improves memory function in mice with Alzheimer’s disease. Neural Regeneration Research. 14(12). 2147–2147. 17 indexed citations
18.
19.
Subbaiah, Papasani V., Veedamali S. Subramanian, & Kewei Wang. (1999). Novel Physiological Function of Sphingomyelin in Plasma. Journal of Biological Chemistry. 274(51). 36409–36414. 45 indexed citations
20.
Tai, Kwok‐Keung, Kewei Wang, & Steven A. Goldstein. (1997). MinK Potassium Channels Are Heteromultimeric Complexes. Journal of Biological Chemistry. 272(3). 1654–1658. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongzhuo Liu Breakdown of academic impact, for papers by Boxuan Ma Breakdown of academic impact, for papers by Shiyi Zuo Breakdown of academic impact, for papers by Dengshuai Wei Breakdown of academic impact, for papers by Batakrishna Jana Breakdown of academic impact, for papers by Xiuli Zheng Breakdown of academic impact, for papers by Lei Luo Breakdown of academic impact, for papers by Wenjun Le Breakdown of academic impact, for papers by Leilei Shi Breakdown of academic impact, for papers by Yang‐Bao Miao
Rankless by CCL
2026